Jasmin Tiro is a Professor in the Department of Public Health Sciences and Associate Director of Cancer Prevention and Population Science for the University of Chicago Medicine Comprehensive Cancer Center. She is a behavioral scientist focused in cancer care delivery research. Her program of research identifies multi-level determinants of cancer prevention and early detection behaviors (e.g., HPV vaccination; breast, cervical, and colorectal cancer screening; hepatocellular cancer surveillance) and uses quantitative and qualitative (mixed) methods to develop, test, and implement interventions. The availability of screening tests to detect breast, cervical, and colorectal cancer early and the HPV vaccine to prevent HPV-related cancers are great public health accomplishments; however, there are segments of the population that still do not receive the full benefits of these behaviors. All of these health behaviors require individuals to interact with health care provider teams and systems. Effective interventions must take into account the local community and policy context and must be easy to implement and sustain. Further, as new technologies (e.g., home-based HPV self-screening) prove effective and are incorporated into clinical guidelines, the need for appropriate and effective communications to transfer knowledge from “bench to bedside” will be even greater in order to maximize the potential of these new technologies in reducing cancer morbidity and mortality. Dr. Tiro's research is at the interface of intervention and implementation science, requires engagement of diverse communities, and is dedicated to promoting equity in cancer outcomes.
University of Texas School of Public Health
Houston, Texas
PhD - Behavioral Sciences
2005
Emory University- Rollins School of Public Health
Atlanta, Georgia
MPH - Behavioral Sciences & Health Education
1999
Rice University
Houston, Texas
BA - Biochemistry
1997
The COVID-19 Pandemic and Changes in Cancer Screening Disparities from 2015 to 2023: An NSHAP Survey Study.
The COVID-19 Pandemic and Changes in Cancer Screening Disparities from 2015 to 2023: An NSHAP Survey Study. J Gen Intern Med. 2026 Jul 16.
PMID: 42463628
No Smoker Left Behind: Evaluation of a Population-Based, Opt-Out Smoking Cessation Program for Patients With Cancer Who Smoke.
No Smoker Left Behind: Evaluation of a Population-Based, Opt-Out Smoking Cessation Program for Patients With Cancer Who Smoke. J Clin Oncol. 2026 Aug 10; 44(23):2176-2186.
PMID: 42202244
BMI and Initiation of Cancer Screening: A Closer Look at Differences by Race, Ethnicity, and Sex in a Multicenter Population.
BMI and Initiation of Cancer Screening: A Closer Look at Differences by Race, Ethnicity, and Sex in a Multicenter Population. Am J Prev Med. 2026 May 25; 71(4):108434.
PMID: 42191051
Community-Centered Funding and Research to Advance Health Equity.
Community-Centered Funding and Research to Advance Health Equity. NEJM Catal Innov Care Deliv. 2026; 7(s2):CAT260103.
PMID: 42455982
Residing in a Food Desert Is Associated With the Development of Colon Cancer Recurrence Following Surgical Resection.
Residing in a Food Desert Is Associated With the Development of Colon Cancer Recurrence Following Surgical Resection. Ann Surg. 2026 Jul 01; 284(1):223-226.
PMID: 41943209
Gaps in care across the cancer screening continuum for cervical, colorectal, and lung cancers.
Gaps in care across the cancer screening continuum for cervical, colorectal, and lung cancers. J Natl Cancer Inst. 2025 Dec 01; 117(12):2556-2570.
PMID: 40929058
Process Mapping to Compare and Improve Management of Abnormal Cervical Cancer Screening Results in Two US Healthcare Systems within the PROSPR Consortium.
Process Mapping to Compare and Improve Management of Abnormal Cervical Cancer Screening Results in Two US Healthcare Systems within the PROSPR Consortium. Cancer Epidemiol Biomarkers Prev. 2025 Nov 03; 34(11):1989-1999.
PMID: 40879504
Longitudinal Adherence to Screening for Colorectal, Cervical, and Lung Cancer in a US Consortium.
Longitudinal Adherence to Screening for Colorectal, Cervical, and Lung Cancer in a US Consortium. J Gen Intern Med. 2026 05; 41(7):1761-1770.
PMID: 41055680
Promoting cervical cancer screening via a mailed HPV self-collection kit: Reactions from screeners and non-screeners.
Promoting cervical cancer screening via a mailed HPV self-collection kit: Reactions from screeners and non-screeners. Patient Educ Couns. 2026 Jan; 142:109374.
PMID: 41067140
Cost-Effectiveness of HPV Self-Testing Options for Cervical Cancer Screening.
Cost-Effectiveness of HPV Self-Testing Options for Cervical Cancer Screening. JAMA Netw Open. 2025 10 01; 8(10):e2534960.
PMID: 41032297
Bill Aston Award for Quality
Texas Hospital Association
2017
Outstanding Mentorship Award
University of Texas Southwestern, Center for Translational Medicine
2014
Cancer Prevention Research Training Merit Award
National Cancer Institute
2007
Fellows Award for Research Excellence
National Institutes of Health
2006
AACR/ACS Scholarship for Behavioral Scientists
American Association for Cancer Research & American Cancer Society
2006
Dr. Ronald Lorimor Scholarship
University of Texas
2004
Dr. Lawrence E. Lamb Scholarship
University of Texas
2002
Delta Omega National Public Health Honor Society
Emory Rollins School of Public Health
1999